Related Experiment Video
Updated: Jun 21, 2025

13:16
Assessment of DNA Contamination in RNA Samples Based on Ribosomal DNA
Published on: January 22, 2018
21.4K
L-DNA-Based Melt Analysis Enables Within-Sample Validation of PCR Products
Nicole A Malofsky1, Dalton J Nelson1, Megan E Pask1
1Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.
Analytical Chemistry
|July 8, 2024
Summary
A new method called LHRM uses synthetic DNA to improve real-time PCR analysis for tuberculosis drug resistance. This approach enhances accuracy in identifying genetic mutations affecting drug susceptibility.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Real-time polymerase chain reaction (PCR) with melt analysis is used to detect PCR products.
- High-resolution melt (HRM) analysis enhances PCR product characterization by improving melt temperature precision.
- Single base changes in tuberculosis (TB) genes like *katG* can confer resistance to first-line drugs such as isoniazid (INH).
Purpose of the Study:
- To develop and validate a reagent-based calibration strategy, LHRM (left-handed HRM), for single-base resolution PCR product characterization.
- To assess the performance of LHRM in classifying *katG* variants associated with isoniazid resistance in TB.
Main Methods:
- A synthetic double-stranded left-handed DNA (L-DNA) melt comparator was added to each sample as an internal standard.
- LHRM and standard HRM were employed to classify nine synthetic *katG* variants with known mutations conferring INH resistance.
- Performance was evaluated using sensitivity and specificity metrics for both single-sample and multiple-sample analyses.
Main Results:
- LHRM achieved classification performance comparable to standard HRM by utilizing within-sample melt differences between L-DNA and unknown PCR products.
- Standard HRM in multiple sample analysis showed 66.7% sensitivity and 98.8% specificity.
- Single-sample LHRM analysis, incorporating L-DNA calibration, demonstrated improved performance with 77.8% sensitivity and 98.7% specificity.
Conclusions:
- LHRM provides a robust, single-sample method for validating PCR products with single-base resolution.
- This approach shows significant promise for applications requiring precise sequence characterization, such as TB drug susceptibility screening.
- LHRM offers a reliable alternative for identifying genetic variations impacting drug efficacy.

